Directors' Holdings

MemberShares 31/12/2020Options 31/12/2020
Dr. Gerd Zettlmeissl, Chairman of the Supervisory Board00
Antoinette Hiebeler-Hasner, Deputy Chair of the Supervisory Board00
Prof. Horst Domdey (until 16/12/2020)39,1250
Dr. Yita Lee (until 16/12/2020)00
Dr. Anthony Man (since 16/12/2020)00
Dr. Keith Manchester1)00
Dr. Frank Mathias20,19746,0892)
Ronald Scott00
Total Supervisory Board59,32246,089
Prof. Dr. Dolores J. Schendel, CEO3)846,29697,500
Dr. Kai Pinkernell, Member of the Executive Management Board073,438
Axel Sven Malkomes, Member of the Executive Management Board075,000
Total Executive Management Board846,296245,938
1) Dr. Manchester is a partner and Head of Life Sciences QVT Financial LP New York, USA. According to the latest voting rights announcement dated 8 June 2018, the funds managed by QVT hold 1,072,879 shares in Medigene AG.
2) The stated number of options corresponds to 124,839 options prior to a capital reduction in 2013.
3) Prof. Schendel indirectly holds 846,296 Medigene shares in her capacity as Managing Director of DJSMontana Holding GmbH, which can be allocated to Prof. Schendel directly.